lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed and are posted here as part of a 12-month trial. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Classification of Glioma Based on Prognostic Alternative Splicing

44 Pages Posted: 22 Feb 2019

See all articles by Songtao Qi

Songtao Qi

Southern Medical University - Department of Neurosurgery

Yawei Liu

Southern Medical University - Department of Neurosurgery

More...

Abstract

Background: Previously developed classifications of glioma have provided enormous advantages for the diagnosis and treatment of glioma. Although the role of alternative splicing (AS) in cancer, especially in glioma, has been validated, a comprehensive analysis of prognostic AS in glioma has not yet been conducted.  

Methods: TCGA glioblastoma (GBM) and low-grade glioma (LGG) datasets were downloaded from TCGA data portal and used to analyzed the prognostic splicing events. Consensus clustering analysis were used to classified glioma samples and correlation analysis was used to characterize regulatory network of splicing factors and splicing events.  

Results: We analyzed prognostic splicing events and proposed novel splicing classifications across pan-glioma samples (labeled pST1-7) and across GBM samples (labeled ST1-3). Distinct splicing profiles between GBM and LGG were observed, and the primary discriminator for the pan-glioma splicing classification was tumor grade. Subtype-specific splicing events were identified; one example is AS of zinc finger proteins, which is involved in glioma prognosis. Furthermore, correlation analysis of splicing factors and splicing events identified SNRPB and CELF2 as hub splicing factors that upregulated and downregulated oncogenic AS, respectively.  

Conclusion: A comprehensive analysis of prognostic AS in glioma was conducted in this study, shedding new light on glioma heterogeneity and providing new insights into glioma diagnosis and treatment.  

Funding: This study was supported by the National Natural Science Foundation of China (Grant nos. 81773290, 81472315, and 81872442), Guangdong Science and Technology Department (2017A030313497, 2016A040403053).

Declaration of Interest: The authors report no competing interests.

Ethical Approval: MIssing

Keywords: Glioma, Glioblastoma, Alternative splicing, Molecular pathology, Prognosis, Classification

Suggested Citation

Qi, Songtao and Liu, Yawei, Classification of Glioma Based on Prognostic Alternative Splicing (July 2, 2019). Available at SSRN: https://ssrn.com/abstract=3334994

Songtao Qi

Southern Medical University - Department of Neurosurgery ( email )

Guangzhou, Guangdong Province
China

Yawei Liu (Contact Author)

Southern Medical University - Department of Neurosurgery ( email )

Guangzhou, Guangdong Province
China

Click here to go to TheLancet.com

Go to TheLancet.com

Paper statistics

Abstract Views
70
Downloads
20